Krabbe Disease Medication

1. Suzuki K, Suzuki Y. Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase. Proc Natl Acad Sci U S A. 1970 Jun. 66(2):302-9. [QxMD MEDLINE Link]. [Full Text].

2. CLELAND WW, KENNEDY EP. The enzymatic synthesis of psychosine. J Biol Chem. 1960 Jan. 235:45-51. [QxMD MEDLINE Link]. [Full Text].

3. Graziano AC, Cardile V. History, genetic, and recent advances on Krabbe disease. Gene. 2015 Jan 15. 555(1):2-13. [QxMD MEDLINE Link]. [Full Text].

4. Krabbe K. A new familial, infantile form of diffuse brain sclerosis. Brain. 1916. 39(1-2):74-114. [Full Text].

5. Suzuki K. Globoid cell leukodystrophy (Krabbe's disease): update. J Child Neurol. 2003 Sep. 18(9):595-603. [QxMD MEDLINE Link]. [Full Text].

6. Viterbo GG, MD, Urgel RJDL. Case 14919. Krabbe disease in a 6-month old male presenting with neurodevelopmental regression and psychomotor delay: A case report. Eurorad. Available at https://www.eurorad.org/case/14919. 2017 Aug 12; Accessed: November 23, 2019.

7. Wenger DA, Escolar ML, Luzi P, Rafi MA. Krabbe disease (Globoid Cell Leukodystrophy). Valle D, Antonarakis S, Ballabio A, Beaudet A, Mitchell GA, eds. The Online Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill; 2019. Part 16: Lysosomal Disorders: [Full Text].

8. Caniglia M, Rana I, Pinto RM, et al. Allogeneic bone marrow transplantation for infantile globoid-cell leukodystrophy (Krabbe's disease). Pediatr Transplant. 2002 Oct. 6(5):427-31. [QxMD MEDLINE Link]. [Full Text].

9. Escolar ML, Poe MD, Provenzale JM, et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med. 2005 May 19. 352(20):2069-81. [QxMD MEDLINE Link]. [Full Text].

10. Krivit W, Shapiro EG, Peters C, et al. Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N Engl J Med. 1998 Apr 16. 338(16):1119-26. [QxMD MEDLINE Link]. [Full Text].

11. Martin PL, Carter SL, Kernan NA, et al. Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol Blood Marrow Transplant. 2006 Feb. 12(2):184-94. [QxMD MEDLINE Link]. [Full Text].

12. Meikle PJ, Ranieri E, Simonsen H, et al. Newborn screening for lysosomal storage disorders: clinical evaluation of a two-tier strategy. Pediatrics. 2004 Oct. 114(4):909-16. [QxMD MEDLINE Link]. [Full Text].

13. Igisu H, Suzuki K. Progressive accumulation of toxic metabolite in a genetic leukodystrophy. Science. 1984 May 18. 224(4650):753-5. [QxMD MEDLINE Link]. [Full Text].

14. Miyatake T, Suzuki K. Globoid cell leukodystrophy: additional deficiency of psychosine galactosidase. Biochem Biophys Res Commun. 1972 Aug 7. 48(3):539-43. [QxMD MEDLINE Link]. [Full Text].

15. White AB, Givogri MI, Lopez-Rosas A, Cao H, van Breemen R, Thinakaran G. Psychosine accumulates in membrane microdomains in the brain of Krabbe patients, disrupting the raft architecture. J Neurosci. 2009 May 13. 29(19):6068-77. [QxMD MEDLINE Link]. [Full Text].

16. Signorini C, Cardile V, Pannuzzo G, et al. Increased isoprostanoid levels in brain from murine model of Krabbe disease - Relevance of isoprostanes, dihomo-isoprostanes and neuroprostanes to disease severity. Free Radic Biol Med. 2019 Aug 1. 139:46-54. [QxMD MEDLINE Link]. [Full Text].

17. Sural-Fehr T, Singh H, Cantuti-Catelvetri L, et al. Inhibition of the IGF-1-PI3K-Akt-mTORC2 pathway in lipid rafts increases neuronal vulnerability in a genetic lysosomal glycosphingolipidosis. Dis Model Mech. 2019 May 23. 12(5):pii: dmm036590. [QxMD MEDLINE Link]. [Full Text].

18. Mohri I, Taniike M, Taniguchi H, et al. Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher. J Neurosci. 2006 Apr 19. 26(16):4383-93. [QxMD MEDLINE Link]. [Full Text].

19. Giri S, Khan M, Nath N, Singh I, Singh AK. The role of AMPK in psychosine mediated effects on oligodendrocytes and astrocytes: implication for Krabbe disease. J Neurochem. 2008 Jun. 105(5):1820-33. [QxMD MEDLINE Link]. [Full Text].

20. Pellegrini D, Del Grosso A, Angella L, et al. Quantitative Microproteomics Based Characterization of the Central and Peripheral Nervous System of a Mouse Model of Krabbe Disease. Mol Cell Proteomics. 2019 Jun. 18(6):1227-1241. [QxMD MEDLINE Link]. [Full Text].

21. Del Grosso A, Angella L, Tonazzini I, et al. Dysregulated autophagy as a new aspect of the molecular pathogenesis of Krabbe disease. Neurobiol Dis. 2019 Sep. 129:195-207. [QxMD MEDLINE Link]. [Full Text].

22. Barczykowski AL, Foss AH, Duffner PK, Yan L, Carter RL. Death rates in the U.S. due to Krabbe disease and related leukodystrophy and lysosomal storage diseases. Am J Med Genet A. 2012 Nov. 158A(11):2835-42. [QxMD MEDLINE Link]. [Full Text].

23. Orsini JJ, Kay DM, Saavedra-Matiz CA, et al. Newborn screening for Krabbe disease in New York State: the first eight years' experience. Genet Med. 2016 Mar. 18(3):239-48. [QxMD MEDLINE Link]. [Full Text].

24. Zlotogora J, Regev R, Zeigler M, et al. Krabbe disease: increased incidence in a highly inbred community. Am J Med Genet. 1985 Aug. 21(4):765-70. [QxMD MEDLINE Link]. [Full Text].

25. Josep D, Alicia M. Current status and use of resources of Lysosomal Storage Diseases: Analysis of a Spanish claims database. Endocr Metab Immune Disord Drug Targets. 2019 Aug 7. doi: 10.2174/1871530319666190807162344. [QxMD MEDLINE Link]. [Full Text].

26. Komatsuzaki S, Zielonka M, Mountford WK, Kölker S, Hoffmann GF, Garbade SF, et al. Clinical characteristics of 248 patients with Krabbe disease: quantitative natural history modeling based on published cases. Genet Med. 2019 Mar 22. 21(10):2208-2215. [QxMD MEDLINE Link]. [Full Text].

27. Wenger DA, Rafi MA, Luzi P. Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications. Hum Mutat. 1997. 10(4):268-79. [QxMD MEDLINE Link]. [Full Text].

28. Loonen MC, Van Diggelen OP, Janse HC, Kleijer WJ, Arts WF. Late-onset globoid cell leucodystrophy (Krabbe's disease). Clinical and genetic delineation of two forms and their relation to the early-infantile form. Neuropediatrics. 1985 Aug. 16(3):137-42. [QxMD MEDLINE Link]. [Full Text].

29. Lyon G, Hagberg B, Evrard P, et al. Symptomatology of late onset Krabbe's leukodystrophy: the European experience. Dev Neurosci. 1991. 13(4-5):240-4. [QxMD MEDLINE Link]. [Full Text].

30. Tokimasa S, Ohta H, Takizawa S, et al. Umbilical cord-blood transplantations from unrelated donors in patients with inherited metabolic diseases: Single-institute experience. Pediatr Transplant. 2008 Sep. 12(6):672-6. [QxMD MEDLINE Link]. [Full Text].

31. Hagberg B. The clinical diagnosis of Krabbe's infantile leucodystrophy. Acta Paediatr Scand. 1963. 52:213.

32. Dunn HG, Lake BD, Dolman CL, Wilson J. The neuropathy of Krabbe's infantile cerebral sclerosis (globoid cell leucodystrophy). Brain. 1969. 92(2):329-44. [QxMD MEDLINE Link]. [Full Text].

33. Korn-Lubetzki I, Dor-Wollman T, Soffer D, Raas-Rothschild A, Hurvitz H, Nevo Y. Early peripheral nervous system manifestations of infantile Krabbe disease. Pediatr Neurol. 2003 Feb. 28(2):115-8. [QxMD MEDLINE Link]. [Full Text].

34. Beltran-Quintero ML, Bascou NA, Poe MD, et al. Early progression of Krabbe disease in patients with symptom onset between 0 and 5 months. Orphanet J Rare Dis. 2019 Feb 18. 14(1):46. [QxMD MEDLINE Link]. [Full Text].

35. Sedel F, Tourbah A, Fontaine B, Lubetzki C, Baumann N, Saudubray JM. Leukoencephalopathies associated with inborn errors of metabolism in adults. J Inherit Metab Dis. 2008 Jun. 31(3):295-307. [QxMD MEDLINE Link]. [Full Text].

36. Duffner PK, Barczykowski A, Kay DM, et al. Later onset phenotypes of Krabbe disease: results of the world-wide registry. Pediatr Neurol. 2012 May. 46(5):298-306. [QxMD MEDLINE Link]. [Full Text].

37. Nyhan WL, Ozand PT. Krabbe disease/galactosylceramide lipidosis/globoid cell leukodystrophy. Atlas of Metabolic Disease. New York, NY: Chapman & Hall Medical; 1998. 581-5.

38. Langan TJ, Barczykowski A, Jalal K, et al. Survey of quality of life, phenotypic expression, and response to treatment in Krabbe leukodystrophy. JIMD Rep. 2019 Apr 11. 47(1):47-54. [QxMD MEDLINE Link]. [Full Text].

39. Nashabat M, Al-Khenaizan S, Alfadhel M. Report of a Case that Expands the Phenotype of Infantile Krabbe Disease. Am J Case Rep. 2019 May 4. 20:643-646. [QxMD MEDLINE Link]. [Full Text].

40. Nicita F, Graziola F, Vigevano F, Bertini E, Capuano A. An unusual case of late-infantile onset Krabbe disease with selective bilateral corticospinal tract involvement, peripheral demyelinating neuropathy, and mild phenotype. Acta Neurol Belg. 2019 Dec. 119(4):619-620. [QxMD MEDLINE Link]. [Full Text].

41. Luzi P, Rafi MA, Wenger DA. Structure and organization of the human galactocerebrosidase (GALC) gene. Genomics. 1995 Mar 20. 26(2):407-9. [QxMD MEDLINE Link]. [Full Text].

42. Scott-Hewitt NJ, Folts CJ, Noble MD. Heterozygous carriers of galactocerebrosidase mutations that cause Krabbe disease have impaired microglial function and defective repair of myelin damage. Neural Regen Res. 2018 Mar. 13(3):393-401. [QxMD MEDLINE Link]. [Full Text].

43. Oehlmann R, Zlotogora J, Wenger DA, Knowlton RG. Localization of the Krabbe disease gene (GALC) on chromosome 14 by multipoint linkage analysis. Am J Hum Genet. 1993 Dec. 53(6):1250-5. [QxMD MEDLINE Link]. [Full Text].

44. Farrell DF, Percy AK, Kaback MM, McKhann GM. Globoid cell (Krabbe's) leukodystrophy: heterozygote detection in cultured skin fibroblasts. Am J Hum Genet. 1973 Nov. 25(6):604-9. [QxMD MEDLINE Link]. [Full Text].

45. Xu C, Sakai N, Taniike M, Inui K, Ozono K. Six novel mutations detected in the GALC gene in 17 Japanese patients with Krabbe disease, and new genotype-phenotype correlation. J Hum Genet. 2006 Apr 11. 51(6):548-54. [QxMD MEDLINE Link]. [Full Text].

46. Pannuzzo G, Graziano ACE, Avola R, Drago F, Cardile V. Screening for Krabbe disease: The first 2 years' experience. Acta Neurol Scand. 2019 Nov. 140(5):359-365. [QxMD MEDLINE Link]. [Full Text].

47. Rafi MA, Luzi P, Chen YQ, Wenger DA. A large deletion together with a point mutation in the GALC gene is a common mutant allele in patients with infantile Krabbe disease. Hum Mol Genet. 1995. 4(8):1285-9. [QxMD MEDLINE Link]. [Full Text].

48. Orsini JJ, Escolar ML, Wasserstein MP, Caggana M. Krabbe Disease. Adam MP, Ardinger HH, Pagon RA, et al., eds. Gene Reviews [Internet]. Seattle, WA: University of Washington, Seattle; 2018 Oct 11. [Full Text].

49. Calderwood L, Wenger DA, Matern D, Dahmoush H, Watiker V, Lee C. Rare Saposin A deficiency: Novel variant and psychosine analysis. Mol Genet Metab. 2019 Aug 5. pii: S1096-7192(19)30410-X. [QxMD MEDLINE Link]. [Full Text].

50. Wenger DA, Sattler M, Clark C, McKelvey H. An improved method for the identification of patients and carriers of Krabbe's disease. Clin Chim Acta. 1974 Oct 30. 56(2):199-206. [QxMD MEDLINE Link]. [Full Text].

51. Madsen AMH, Wibrand F, Lund AM, Ek J, Dunø M, Østergaard E. Genotype and phenotype classification of 29 patients affected by Krabbe disease. JIMD Rep. 2019 Mar 14. 46(1):35-45. [QxMD MEDLINE Link]. [Full Text].

52. Bowen DM, Radin NS. Cerebroside galactosidase: a method for determination and a comparison with other lysosomal enzymes in developing rat brain. J Neurochem. 1969 Apr. 16(4):501-11. [QxMD MEDLINE Link]. [Full Text].

53. Tokushige SI, Sonoo T, Maekawa R, et al. Isolated pyramidal tract impairment in the central nervous system of adult-onset Krabbe disease with novel mutations in the GALC gene. Brain Dev. 2013 Jun. 35(6):579-81. [QxMD MEDLINE Link]. [Full Text].

54. Camelier M, Civallero G, De Mari J, Burin M, Giugliani R. Galactocerebrosidase assay on dried-leukocytes impregnated in filter paper for the detection of Krabbe disease. Clin Chim Acta. 2015 Jan 1. 438:178-80. [QxMD MEDLINE Link]. [Full Text].

55. Duffner PK, Caggana M, Orsini JJ, et al. Newborn screening for Krabbe disease: the New York State model. Pediatr Neurol. 2009 Apr. 40(4):245-52; discussion 253-5. [QxMD MEDLINE Link]. [Full Text].

56. Lane B, Carroll BA, Pedley TA. Computerized cranial tomography in cerebral diseases of white matter. Neurology. 1978 Jun. 28(6):534-44. [QxMD MEDLINE Link]. [Full Text].

57. Brockmann K, Dechent P, Wilken B, Rusch O, Frahm J, Hanefeld F. Proton MRS profile of cerebral metabolic abnormalities in Krabbe disease. Neurology. 2003 Mar 11. 60(5):819-25. [QxMD MEDLINE Link]. [Full Text].

58. Cousyn L, Law-Ye B, Pyatigorskaya N, et al. Brain MRI features and scoring of leukodystrophy in adult-onset Krabbe disease. Neurology. 2019 Aug 13. 93 (7):e647-e652. [QxMD MEDLINE Link]. [Full Text].

59. Provenzale JM, Peddi S, Kurtzberg J, Poe MD, Mukundan S, Escolar M. Correlation of neurodevelopmental features and MRI findings in infantile Krabbe's disease. AJR Am J Roentgenol. 2009 Jan. 192(1):59-65. [QxMD MEDLINE Link]. [Full Text].

60. Udow S, Bunge M, Ryner L, Mhanni AA, Salman MS. Prolonged survival and serial magnetic resonance imaging/magnetic resonance spectroscopy changes in infantile Krabbe disease. Pediatr Neurol. 2012 Oct. 47(4):299-302. [QxMD MEDLINE Link]. [Full Text].

61. Provenzale JM, Escolar M, Kurtzberg J. Quantitative analysis of diffusion tensor imaging data in serial assessment of krabbe disease. Ann N Y Acad Sci. 2005 Dec. 1064:220-9. [QxMD MEDLINE Link]. [Full Text].

62. Austin JH, Lehfeldt D. Studies in globoid (Krabbe) leucodystrophy. 3. Significance of experimentally produced globoid-like elements in rat white matter and spleen. J Neuropathol Exp Neurol. 1965 Apr. 24:265-89. [QxMD MEDLINE Link].

63. Duffner PK, Caviness VS Jr, Erbe RW, et al. The long-term outcomes of presymptomatic infants transplanted for Krabbe disease: report of the workshop held on July 11 and 12, 2008, Holiday Valley, New York. Genet Med. 2009 Jun. 11(6):450-4. [QxMD MEDLINE Link]. [Full Text].

64. Allewelt H, Taskindoust M, Troy J, et al. Long-term functional outcomes after hematopoietic stem cell transplant for Early Infantile Krabbe Disease. Biol Blood Marrow Transplant. 2018 Nov. 24(11):2233-2238. [QxMD MEDLINE Link]. [Full Text].

65. Page KM, Stenger EO, Connelly JA, et al. Hematopoietic stem cell transplantation to treat leukodystrophies: clinical practice guidelines from the Hunter’s Hope Leukodystrophy Care Network. Biol Blood Marrow Transplant. 2019 Sep 6. pii: S1083-8791(19)30571-3. [QxMD MEDLINE Link]. [Full Text].

66. Luzi P, Abraham RM, Rafi MA, Curtis M, Hooper DC, Wenger DA. Effects of treatments on inflammatory and apoptotic markers in the CNS of mice with globoid cell leukodystrophy. Brain Res. 2009 Dec 1. 1300:146-58. [QxMD MEDLINE Link]. [Full Text].

67. Pan X, Sands SA, Yue Y, Zhang K, LeVine SM, Duan D. An engineered galactosylceramidase construct improves AAV gene therapy for Krabbe disease in twitcher mice. Hum Gene Ther. 2019 Sep. 30(9):1039-1051. [QxMD MEDLINE Link]. [Full Text].

Anna V Blenda, PhD Clinical Associate Professor, Department of Biomedical Sciences, University of South Carolina School of Medicine, Greenville

Anna V Blenda, PhD is a member of the following medical societies: American Association for Cancer Research, American College of Medical Genetics and Genomics, American Society for Microbiology

Disclosure: Nothing to disclose.

Stephen L Nelson, Jr, MD, PhD, FAACPDM, FAAN, FAAP, FANA Professor of Pediatrics, Neurology, Neurosurgery, and Psychiatry, Medical Director, Tulane Center for Autism and Related Disorders, Tulane University School of Medicine; Pediatric Neurologist and Epileptologist, Ochsner Hospital for Children; Professor of Neurology, Louisiana State University School of Medicine

Stephen L Nelson, Jr, MD, PhD, FAACPDM, FAAN, FAAP, FANA is a member of the following medical societies: American Academy for Cerebral Palsy and Developmental Medicine, American Academy of Neurology, American Academy of Pediatrics, American Epilepsy Society, American Medical Association, American Neurological Association, Association of Military Surgeons of the US, Child Neurology Society, Southern Pediatric Neurology Society

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Luis O Rohena, MD, PhD, FAAP, FACMG Deputy Chief, Department of Pediatrics, Chief, Medical Genetics, San Antonio Military Medical Center; Associate Professor of Pediatrics, Uniformed Services University of the Health Sciences, F Edward Hebert School of Medicine; Associate Professor of Pediatrics, University of Texas Health Science Center at San Antonio

Luis O Rohena, MD, PhD, FAAP, FACMG is a member of the following medical societies: American Academy of Pediatrics, American Chemical Society, American College of Medical Genetics and Genomics, American Society of Human Genetics

Disclosure: Nothing to disclose.

Erawati V Bawle, MD, FAAP, FACMG Retired Professor, Department of Pediatrics, Wayne State University School of Medicine

Erawati V Bawle, MD, FAAP, FACMG is a member of the following medical societies: American College of Medical Genetics and Genomics, American Society of Human Genetics

Disclosure: Nothing to disclose.

David H Tegay, DO, FACMG Associate Professor and Chair, Department of Medicine, NYIT College of Osteopathic Medicine; Director, Genetics Division, Department of Pediatrics, Nassau University Medical Center

David H Tegay, DO, FACMG is a member of the following medical societies: American College of Medical Genetics and Genomics, American College of Osteopathic Internists, American Osteopathic Association, Federation of American Societies for Experimental Biology, American Society of Human Genetics

Disclosure: Nothing to disclose.

David Flannery, MD, FAAP, FACMG Vice Chair of Education, Chief, Section of Medical Genetics, Professor, Department of Pediatrics, Medical College of Georgia

David Flannery, MD, FAAP, FACMG is a member of the following medical societies: American Academy of Pediatrics, American College of Medical Genetics and Genomics

Disclosure: Nothing to disclose.

Rahmat A Balogun, DO, MS New York College of Osteopathic Medicine at New York Institute of Technology

Rahmat A Balogun, DO, MS is a member of the following medical societies: American Osteopathic Association, Society for Neuroscience, Student National Medical Association

Disclosure: Nothing to disclose.

Reem Saadeh-Haddad, MD Associate Professor, Clinical Geneticist, Department of Pediatrics and Medicine, MedStar Georgetown University Hospital; Clinical Geneticist, Department of Oncology, Sibley Memorial Hospital; Module Director-Pediatric and Clinical Genetics, Georgetown University School of Medicine

Reem Saadeh-Haddad, MD is a member of the following medical societies: National Arab American Medical Association

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article